MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Determinants of quality of life in a large, online cohort of patients with Parkinson’s disease

    M. Bock, E. Brown, C. Tanner (San Francisco, CA, USA)

    Objective: To investigate demographic differences and key determinants of quality of life (QOL) in a large, online cohort. Background: PD is a multisystem, progressive illness…
  • MDS Virtual Congress 2020

    MDS Translation Program for MDS-UPDRS, UDysRS, and MDS-NMS

    S. Luo, N. LaPelle, P. Martin, C. Goetz, G. Stebbins (Durham, NC, USA)

    Objective: To summarize the status of the ongoing MDS-sponsored translation programs for non-English versions of the MDS-UPDRS, UDysRS, and MDS-NMS. Background: The MDS-UPDRS, UDysRS, and…
  • MDS Virtual Congress 2020

    Directional programming in GPi-DBS for Parkinson’s disease and retrospective assessment of UPDRS III outcomes: First clinical case series

    H. Leal Bailey, J. Donnelly, S. Pallavaram, J. Ramirez Castaneda (San Antonio, TX, USA)

    Objective: To describe our methodology for directional programming in GPi-DBS for PD and report on retrospective assessment of stable programming settings, energy savings using specific…
  • MDS Virtual Congress 2020

    Characterization of the swallow function in Parkinson patients with or without STN DBS

    T. Xie, L. Bloom, P. Warnke, W. Kang, A. Dachman, E. MacCracken (Chicago, IL, USA)

    Objective: To characterize the swallow function in Parkinson patients with or without bilateral STN DBS. Background: Although aspiration is one of the major causes of…
  • MDS Virtual Congress 2020

    Goalkeeper Game: a new assessment tool for prediction of gait performance under complex condition in people with Parkinson’s disease

    R. Stern, M. d'Alencar, Y. Uscapi, M. Gubitoso, A. Roque, A. Helene, M. Piemonte (São Carlos, Brazil)

    Objective: To investigate the use of the GG to predict impairment in gait performance under complex conditions in PPD and compare its predictive power with…
  • MDS Virtual Congress 2020

    Transcranial brain sonography can distinguish drug induced parkinsonism from idiopathic Parkinson’s disease in Korean?

    M. Park, H. Park (Daegu, Republic of Korea)

    Objective: ​​​​​​This was a prospective study to evaluate distinction of trans cranial sonograph(TCS) findings of the SN(sustantia nigra) in patients who were recent-onset of durg…
  • MDS Virtual Congress 2020

    Study on the clinical features of Parkinson’s disease with probable rapid eye movement sleep behavior disorder

    J. Liu, Y. Xiang, C. Wan, X. Yan, B. Tang, J. Guo (Changsha, Hunan, China)

    Objective: To investigate the clinical features and associated factors of Parkinson's disease (PD) patients with probable rapid eye movement sleep behavior disorder (PD-pRBD) Background: RBD…
  • MDS Virtual Congress 2020

    Progressive supranuclear palsy: Common metabolic pattern in different variants

    G. Martí-Andrés, L. Van Bommel, S. Meles, M. Riverol, R. Valentí, R.V Kogan, R.J Renken, V. Gurvits, T. Van Laar, M. Pagani, E. Prieto, M.R Luquin, K.L Leenders, J. Arbizu (Pamplona, Spain)

    Objective: To define and cross-validate the brain glucose metabolic abnormalities in patients with a diagnosis of different PSP variants. Background: It remains unclear whether the supportive…
  • MDS Virtual Congress 2020

    The Future of Hospitalization for People with Parkinson’s Disease

    A. Wallis, D. Perret (Miami, FL, USA)

    Objective: To share the discussion of the December 6, 2019 Parkinson’s Hospitalization Convening. Background: On December 6, 2019, The Parkinson’s Foundation (PF)  assembled thought leaders…
  • MDS Virtual Congress 2020

    Modifiable Comorbidities Associated with Rate of Cognitive Decline in Parkinson’s Disease

    E. Forbes, T. Tropea, S. Mantri, J. Morley (Philadelphia, PA, USA)

    Objective: To determine the association between baseline modifiable comorbidities, including cardiovascular disease risk factors, mood disorders, and sleep characteristics, and the rate of change in…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley